4,6-Dichloro-2-Methylpyrimidine CAS 1780-26-3 Ubunyulu ≥99.5% (GC) Factory Hot Sale Factory Image Featured

I-4,6-Dichloro-2-Methylpyrimidine CAS 1780-26-3 Ubunyulu ≥99.5% (GC) IFactory Hot Sale

Inkcazelo emfutshane:

Igama leKhemikhali: 4,6-Dichloro-2-Methylpyrimidine

CAS: 1780-26-3

Ubunyulu: ≥99.5% (GC)

Imbonakalo: Umgubo weCrystalline oMhlophe okanye oMhlophe

Umgangatho ophezulu, iMveliso yoRhwebo

Umbindi weDasatinib / Moxonidine

E-Mail: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 4,6-Dichloro-2-Methylpyrimidine (CAS: 1780-26-3) with high quality, commercial production. We can provide COA, worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com

Iipropati zeMichiza:

Igama leMchiza	4,6-Dichloro-2-Methylpyrimidine
Izithethantonye	I-2-Methyl-4,6-Dichloropyrimidine;2,4-Dichloro-6-Methylpyrimidine
Inombolo yeCAS	1780-26-3
Inombolo yeCAT	RF-PI687
Ubume beStokhwe	Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli	I-C5H4Cl2N2
Ubunzima beMolekyuli	163.00
Indawo yokunyibilika	41.5 ~ 45.5℃ (ilayiti.)
Ukunyibilika (Nyibilika ngaphakathi)	IMethanol
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Umgubo weCrystalline oMhlophe okanye oMhlophe
Ubunyulu / Indlela yokuHlalutya	≥99.5% (GC)
Ilahleko ekomisweni	≤0.50%
Intsalela kwi-Ignition	≤0.20%
Ukungacoceki Okukodwa	≤0.50%
Ukungcola ngokupheleleyo	≤0.50%
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	Phakathi kwezamayeza;I-Dasatinib / i-Moxonidine ePhakathi

I-4,6-Dichloro-2-Methylpyrimidine (CAS: 1780-26-3) Indlela yeNkqubo

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma

Izinto eziluncedo:

FAQ:

Isicelo:

I-4,6-Dichloro-2-Methylpyrimidine (i-CAS: 1780-26-3) isetyenziswe kwi-synthesis ye-pharmaceutical intermediates kunye ne-APIs.Iimveliso zokulungiselela: iMoxonidine (CAS: 75438-57-2);I-Dasatinib (CAS: 302962-49-8);I-Dasatinib Monohydrate (CAS: 863127-77-9);I-4-Chloro-2,6-Dimethylpyrimidine (i-CAS: 4472-45-1);I-4-Amino-6-Chloro-2-Methylpyrimidine (CAS: 1749-68-4).I-Moxonidine luhlobo olutsha lwechiza le-antihypertensive, elisetyenziswa ngokuqhelekileyo kunyango lwe-hypertension ebalulekileyo.Xa kuthelekiswa ne-antihypertensive endala esebenza phakathi, i-Moxonidine ibophelela ngokuhambelana kakhulu ne-imidazoline I1-receptor kune-α2-receptor.I-Dasatinib ngumlomo onamandla we-oncogenic kinase inhibitor, enokuthintela umqondiso wokuphindaphinda i-cell cell replication, ngoMeyi 2009, i-US Food and Drug Administration (FDA) ivume ngokusemthethweni ukuthengiswa kwe-dasatinib, isetyenziselwa unyango lweentlobo ezahlukeneyo ezingapheliyo. i-myeloid leukemia (CML), kuquka unyango lwe-leukemia ye-myeloid engapheliyo enganyangekiyo okanye enganyamezeliyo kwiinkqubo zonyango ezibandakanya i-imatinib mesylate., i-Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + BONKE) kunye nokunyangwa kwezigulane ezinamathumba aqinileyo.